Enzolytics, Inc. (ENZC)
OTCMKTS · Delayed Price · Currency is USD
0.0007
+0.0001 (16.67%)
Aug 15, 2025, 3:12 PM EDT
Enzolytics Market Cap
Enzolytics has a market cap or net worth of $3.38 million as of August 15, 2025. Its market cap has decreased by -69.61% in one year.
Market Cap
3.38M
Enterprise Value
n/a
Revenue
46.59K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since December 29, 2008, Enzolytics's market cap has decreased from 106.80M to 3.38M, a decrease of -96.83%. That is a compound annual growth rate of -18.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 2.90M | -36.84% |
| Dec 31, 2024 | 4.59M | -91.73% |
| Dec 29, 2023 | 55.53M | -46.84% |
| Dec 30, 2022 | 104.44M | -45.90% |
| Dec 31, 2021 | 193.06M | -12.10% |
| Dec 31, 2020 | 219.64M | 56,505.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.72M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 608.19M |
| Glass House Brands | 561.16M |
| American Oncology Network | 385.65M |
| Northwest Biotherapeutics | 332.06M |
| CytoDyn | 300.75M |